Showing results (211-220 of 286) with videos related to
Sort By:
Pageof 29
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2008
Correlation of kinase genotype and clinical outcome in the North American Intergroup Phase III Trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology GroupMichael C Heinrich, Kouros Owzar, Christopher L Corless, et al.The Journal of Molecular Diagnostics : JMD|July 6, 2011
Multiplex mutation screening by mass spectrometry evaluation of 820 cases from a personalized cancer medicine registryCarol Beadling, Michael C Heinrich, Andrea Warrick, et al.Breast Cancer Research and Treatment|August 10, 2012
Cross-platform pathway-based analysis identifies markers of response to the PARP inhibitor olaparibAnneleen Daemen, Denise M Wolf, James E Korkola, et al.Cell Systems|December 27, 2016
Context Specificity in Causal Signaling Networks Revealed by Phosphoprotein ProfilingSteven M Hill, Nicole K Nesser, Katie Johnson-Camacho, et al.Iscience|September 9, 2024
Multiplex imaging of localized prostate tumors reveals altered spatial organization of AR-positive cells in the microenvironmentÇiğdem Ak, Zeynep Sayar, Guillaume Thibault, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2008
Phase II, open-label study evaluating the activity of imatinib in treating life-threatening malignancies known to be associated with imatinib-sensitive tyrosine kinasesMichael C Heinrich, Heikki Joensuu, George D Demetri, et al.Nature Communications|August 9, 2025
Cell free RNA detection of pancreatic cancer in pre diagnostic high risk and symptomatic patientsTravis W Moore, Elias Spiliotopoulos, Rowan L Callahan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2011
Phase II, open-label, single-arm trial of imatinib mesylate in patients with metastatic melanoma harboring c-Kit mutation or amplificationJun Guo, Lu Si, Yan Kong, et al.Proceedings of the National Academy of Sciences of the United States of America|January 13, 2006
A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cellsRobert B West, Brian P Rubin, Melinda A Miller, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2009
Molecular target modulation, imaging, and clinical evaluation of gastrointestinal stromal tumor patients treated with sunitinib malate after imatinib failureGeorge D Demetri, Michael C Heinrich, Jonathan A Fletcher, et al.Pageof 29